Wednesday, October 08, 2025
New Vaccine Shows Promise Against Typhoid and Invasive Salmonella in First Human Trial
Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.
Tuesday, October 07, 2025
Nationally-Recognized Pathologist Paul N. Staats, MD, Named Chair of Pathology at University of Maryland School of Medicine
Paul N. Staats, MD, a nationally recognized expert in cytopathology and gynecologic pathology, has been appointed Chair of the University of Maryland School of Medicine’s (UMSOM) Department of Pathology, effective September 29. A UMSOM Professor of Pathology, Dr. Staats has served as the Interim Chair of Pathology since February 2024, after longtime Chair Sanford A. Stass, MD, stepped down.
Thursday, October 02, 2025
Thomas Scalea, MD, inducted into American College of Surgeons Academy of Master Surgeon Educators
Thomas M. Scalea, MD, the Honorable Francis X. Kelly Distinguished Professor of Trauma Surgery and Director of the Program in Trauma at the University of Maryland School of Medicine was inducted into the American College of Surgeons (ACS) Academy of Master Surgeon Educators during an event in Chicago held on September 19.
Tuesday, September 30, 2025
University of Maryland School of Medicine Launches Global Health Alliance
Global health research in U.S. academic medical centers is facing dire threats with proposed cuts to the federal budget that would reduce funding for global health programs by 62 percent, from $10 billion to $3.8 billion. Cuts include reducing funding for the President’s Malaria Initiative by nearly 45 percent, zeroing out U.S. funding for Gavi, the Vaccine Alliance, which received $300 million this year, as well as discontinuing $1.7 billion annually for the Global Fund to Fight AIDS.
Thursday, September 25, 2025
Leading Maternal Health Physician-Scientist Andreea Creanga, MD, PhD, Named Chair of the Department of Epidemiology and Public Health at the University of Maryland School of Medicine
University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that Andreea Creanga, MD, PhD, a distinguished and internationally recognized leader in maternal and perinatal health, has been appointed the new Chair of the Department of Epidemiology and Public Health. She will also be installed as the Simon and Bessie Grollman Distinguished Professor. Her appointment is effective December 2025.
Wednesday, September 17, 2025
New Fellowship Launches to Help End the Organ Shortage Crisis
The A. James Clark School of Engineering at the University of Maryland, College Park (UMCP) and the University of Maryland School of Medicine (UMSOM) at the University of Maryland, Baltimore (UMB) are proud to announce the selection of Martin Carrasco as the first inaugural Mickey Dale Family Foundation Endowed Distinguished Graduate Fellowship in Bioengineering.
Monday, September 15, 2025
Get to Know: Dr. Jeremy Davis
Jeremy L. Davis, MD, joined the University of Maryland School of Medicine (UMSOM) as Chief of the Division of Surgical Oncology in January 2025. He also serves as the Surgical Oncology Lead for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
Friday, September 12, 2025
In Memoriam: Sanford Stass, MD, Longtime Chair of the Department of Pathology and the Department of Medical & Research Technology
The University of Maryland School of Medicine Community mourns the passing of one of its most distinguished long-time faculty members and department chairs, Sanford “Sandy” A. Stass, MD. A former chair of the Department of Pathology and Department of Medical & Research Technology, Dr. Stass stepped down in early 2024 from his leadership roles but continued as a Professor of Pathology until his retirement in November 2024. He passed away on September 9 at age 82.
Thursday, September 11, 2025
UM School of Medicine Researchers Join Partnership to Establish New Center to Study Resilience and Aging
With the percentage of Americans ages 65 and older projected to increase by 47 percent by 2050, there’s an urgent need to close the large healthcare gap between those who age well into their 80’s and those who suffer long term disabilities from chronic illnesses like diabetes, kidney disease, and heart disease. To address these important research questions, the National Institute of Aging will fund a new center—that will be led by faculty at the University of Maryland--to identify the most important factors in the population that lead to healthy aging or aging resilience.
Monday, September 08, 2025
Internationally Recognized Malaria Researcher Stefan Kappe, PhD, Appointed New Director of the UM School of Medicine's Center for Vaccine Development and Global Health
University of Maryland School of Medicine Dean, Mark T. Gladwin, MD, announced today the appointment of distinguished parasitologist and immunologist Stefan Kappe, PhD, to be the new Director of the school’s Center for Vaccine Development and Global Health (CVD). Known for his landmark research on the early phases of malaria parasite infection in the liver, Dr. Kappe is a Professor and the Associate Vice Chair of Basic Science Research in the Department of Pediatrics at the University of Washington in Seattle. He is also a senior principal investigator at the Center for Global Infectious Disease Research at Seattle Children’s Research Institute where he until recently also served as an Associate Director.
Monday, August 25, 2025
Internationally-Recognized Emergency Medicine Pioneer Dr. Brian Browne to Step Down as Department Chair at UM Medicine
Dr. Brian J. Browne, MD, FACEP, FAAEM, longtime Professor and Founding Chair of the Department of Emergency Medicine at the University of Maryland School of Medicine and award-winning pioneer in the field of emergency care, today announced his decision to step down as Department Chair effective September 1, 2025. Dr. Michael E. Winters MD, Professor of Emergency Medicine and Vice Chair for Clinical and Administrative Affairs, as agreed to serve as Interim Department Chair beginning on that date. Dr. Browne will remain on the faculty until the end of 2025, when he plans to retire.
Monday, August 25, 2025
University of Maryland School of Medicine Researchers Detail Reliable Measurement for Blood-Brain Barrier Opening Using Focused Ultrasound
Researchers from the University of Maryland School of Medicine (UMSOM), Brigham and Women’s Hospital in Boston and other North American institutions, have provided the first technical description for using focused ultrasound to reliably open the blood-brain barrier. The findings, recently published in Device, pave the way for expanding the use of this experimental device to open the blood-brain barrier to improve treatments and diagnostics for patients with brain tumors and other neurological disorders.
Monday, August 25, 2025
Generative AI Uncovers Undetected Bird Flu Exposure Risks in Maryland Emergency Departments
Researchers from the University of Maryland School of Medicine developed a new and highly effective application of an artificial intelligence (AI) tool to quickly scan notes in electronic medical records and identify high-risk patients who may have been infected with H5N1 avian influenza or “bird flu”, according to findings published this week in the journal Clinical Infectious Diseases.
Wednesday, August 20, 2025
29th Annual White Coat Ceremony Welcomes Class of 2029
In a highly anticipated annual ritual for incoming medical school students, the University of Maryland School of Medicine (UMSOM) Class of 2029 received their first white coats on August 8. The 173 new students gathered at the historic Hippodrome Theatre along with family, friends, faculty, and staff to take part in the decades old tradition of the White Coat Ceremony.
Tuesday, August 12, 2025
New Protein Therapy Shows Promise as First-Ever Antidote for Carbon Monoxide Poisoning
University of Maryland School of Medicine (UMSOM) researchers, along with their colleagues, engineered a new molecule that appears promising as an effective antidote for carbon monoxide poisoning with fewer side effects than other molecules currently being tested, according to a new study published in the journal PNAS.
Friday, August 08, 2025
Student Research Forum Highlights Value of Mentorship Programs
In a moment when proposed Federal budget cuts threaten the future of biomedical research and training, more than 150 student interns—from middle school through medical school—presented their scientific abstracts last month at the annual summer Student Research Forum. Headed by the University of Maryland School of Medicine’s (UMSOM) Office of Student Research, the event highlighted the value of investing in the next generation of biomedical innovators.
Thursday, August 07, 2025
Get to Know: Dr. Peter Manza
Peter Manza, PhD, joined the University of Maryland School of Medicine (UMSOM) as an Assistant Professor of Psychiatry in January 2025. He’s also a faculty member at the UMSOM Kahlert Institute for Addiction Medicine, which UMSOM Dean Mark T. Gladwin, MD, established in 2023 to pursue innovation in addiction treatments and research.
Tuesday, August 05, 2025
Two UMSOM Professors Receive Board of Regents Faculty Awards
Two distinguished University of Maryland School of Medicine (UMSOM) professors were honored with prestigious University System of Maryland (USM) Board of Regents Faculty Awards on April 11.
Tuesday, August 05, 2025
UMSOM Faculty join engAGE with Heart Trust-Based Community Health Summit
On July 30, faculty community leaders from the University of Maryland School of Medicine participated in a community health summit alongside Baltimore City Council President Zeke Cohen, Baltimore Mayor Brandon Scott, and Maryland State Senator Cory V. McCray. The event was organized by engAGE with Heart, led by Reverend Dr. Terris King, Pastor of Liberty Church of God, who described trust-based community hubs as “not just a program, but a ministry.” His church stands as a model for how integrated care and community engagement can transform healthcare delivery.
Monday, August 04, 2025
New Review Highlights Significant Need for Comprehensive Care for Gun Violence Survivors
A new review article published in JAMA underscores the critical need for comprehensive long-term medical care for patients treated for firearm injuries, which has become an epidemic in the U.S. fueled by years of rising gun violence. More than 48,000 people died of firearm injuries in the U.S. in 2022, according to the Centers for Disease Control and Prevention with 120,000 suffering from gunshot wounds that they recover from.
Friday, July 25, 2025
New Research Simulates Cancer Cell Behavior
In the same vein as weather forecast models that predict developing storms, researchers now have developed a method to predict the cell activity in tissues over time. The new software combines genomics technologies with computational modeling to predict cell changes in behavior, such as communication between cells that could cause cancer cells to flourish.
Thursday, July 24, 2025
Preoperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery Without Increasing Patients’ Pain Level, New Research Shows
Preoperative counseling significantly reduced opioid use by patients undergoing anterior cruciate ligament (ACL) reconstruction, a common knee surgery, with no increase in pain following the procedure, according to new research by orthopaedic surgeons at the University of Maryland School of Medicine (UMSOM). The findings of the randomized clinical trial of 121 patients who had surgery at the University of Maryland Rehabilitation & Orthopaedic Institute (UM Rehab & Ortho) were published recently in the Journal of Bone and Joint Surgery.
Wednesday, July 23, 2025
Getting to Know: Elana Fertig, PhD, Director of the Institute for Genome Sciences at the University of Maryland School of Medicine
Elana J. Fertig, PhD, FAIMBE, joined the University of Maryland School of Medicine (UMSOM) in December 2024 as a Professor of Medicine and the new Director of the School’s Institute for Genome Sciences (IGS). She’s also the Associate Director for Quantitative Science in the Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
Monday, July 21, 2025
Distinguished Physician-Scientist and Nationally Recognized Pulmonologist Roberto Machado, MD, Named Chair of the Department of Medicine at the University of Maryland School of Medicine
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Roberto Machado, MD, Chief of Pulmonary, Critical Care, Sleep, and Occupational Medicine at the Indiana University School of Medicine, has been appointed the new Chair of the Department of Medicine, the largest department at UMSOM with more than 400 full-time faculty members and 12 divisions. He will also serve as the Physician-In-Chief at the University of Maryland Medical Center.
Tuesday, July 15, 2025
Oldest Known Portrait of John Davidge Discovered in Defunct Fells Point Eatery
It could be called a finding of fate: The recent discovery of a more than 180-year-old painting of John Beale Davidge, MD, the founder of the University of Maryland School of Medicine. The portrait had been stashed in a storage closet at the former Bertha’s Mussels Restaurant in Fells Point.
Monday, July 14, 2025
UM School of Medicine Team Wins NIH TARGETED Challenge with Brain Genome Editing Technology
A team of researchers from the University of Maryland School of Medicine (UMSOM) recently won a $250,000 prize from the National Institutes of Health (NIH) to improve technologies for delivering genome editing tools to targeted cells in the body. They were one of four winners in a competition after successfully demonstrating a new technique to deliver genome editing biotechnology across the blood-brain barrier to brain cells in preclinical models.
Wednesday, July 09, 2025
University of Maryland School of Medicine Launches Groundbreaking Study on THC/CBD Therapy for Dementia-Related Agitation at End of Life
The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging to explore a potential treatment for agitation in patients with dementia nearing the end of life. The study focuses on an investigational oral drug, T2:C100, which contains the two active ingredients in cannabis: THC and CBD.
Monday, July 07, 2025
Dr. Deanna L. Kelly Named Director of the Maryland Psychiatric Research Center
Mark T. Gladwin, MD, Dean of the University of Maryland School of Medicine announced today that Deanna L. Kelly, PharmD, BCPP, a Professor of Psychiatry at the University of Maryland School of Medicine, has been named Director of the Maryland Psychiatric Research Center (MPRC), Dr. Kelly is a internationally recognized clinician-scientist specializing in the advancement of treatments for psychotic disorders and schizophrenia, after serving as Interim Director for three years.
Tuesday, July 01, 2025
UM School of Medicine Confocal Core Facility Offers Super-Resolution Microscopy to Enhance Imaging of Subcellular Structures
The UMSOM Confocal Microscopy Core facility is now offering researchers access to a state-of-the-art STED microscope that provides super-resolution imaging capabilities. It is the latest addition of an Abberior Facility Line STED microscope.
Monday, June 30, 2025
In Memoriam: Dr. Stanley Sol Schocket
Stanley Sol Schocket passed away on June 24, 22025, in Baltimore, Maryland, at the age of 90. He earned his MD from the University of Maryland School of Medicine in 1959, and later served as a faculty member and leader in the Department of Ophthalmology from 1968 until his retirement in 2019.
Monday, June 30, 2025
UM School of Medicine Research Reveals Alarming Health and Resource Burden of Sleep Apnea Among U.S. Active-Duty Military
With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and other health ills, a new study conducted by the University of Maryland School of Medicine (UMSOM) carefully analyzed the toll that this sleep disorder takes on U.S. active-duty military members, and their analysis was alarming: They found that soldiers with sleep apnea who are serving on the front lines are more than four times more likely to experience post traumatic stress disorder and three times more likely to suffer a traumatic brain injury compared to those who don’t have the condition.
Wednesday, June 25, 2025
Getting to Know: Shawn Kwatra, MD, University of Maryland School of Medicine Chief of Dermatology
In March 2024, Shawn Kwatra, MD, joined the University of Maryland School of Medicine (UMSOM), where he serves as the Joseph W. Burnett Endowed Professor and Chair of Dermatology.
Tuesday, June 24, 2025
University of Maryland Launches B.S.-M.D. Program to Bridge Engineering, Data Science, and Medicine
The University of Maryland, College Park (UMCP) and the University of Maryland School of Medicine (UMSOM) at the University of Maryland, Baltimore (UMB) have launched a B.S.-M.D. program. This dual-degree program is designed to prepare highly motivated undergraduate students majoring in engineering, computer science, or mathematics to succeed in medical school. The program aims to recruit more engineers and data scientists into clinical professions, helping to bring new skills and perspectives into the future of medicine.
Wednesday, June 18, 2025
In Memoriam: Dr. George L. Drusano
George Louis Drusano passed away on June 10, 2025, in Orlando, Florida, following a long-term illness. He was 75 years old.
Monday, June 16, 2025
Kahlert Institute’s 2nd Annual Research Symposium: Focus on New Addiction Treatments, Help for Cravings
The University of Maryland School of Medicine (UMSOM) Kahlert Institute for Addiction Medicine hosted its second annual Research Symposium on May 28, bringing together dozens of researchers and clinicians to share the latest research into the underlying biology and treatment of substance use disorders.
Wednesday, June 11, 2025
Rural-MD Scholars Prepare for Careers in Healthcare on Maryland’s Eastern Shore
In an effort to address the healthcare shortage facing Maryland's nearly half-million residents who live on the rural Eastern Shore, the University of Maryland School of Medicine last year established a program to train and place students in rural healthcare settings. This academic year, three students who received full-tuition scholarships and were accepted into the newly named Rural-MD Scholars program started gaining insight into their future practice on the Eastern Shore through interactions with local healthcare professionals, community engagement, and hands-on clinical experiences.
Tuesday, June 10, 2025
Meet The Board of Visitors
The University of Maryland School of Medicine (UMSOM) is pleased to formally acknowledge the 11 newest members of its Board of Visitors, who have joined the board over the past two academic years. These distinguished individuals bring a diverse range of expertise spanning medicine, law, business, philanthropy, and public service.
Tuesday, June 10, 2025
Longtime Anesthesiology Department Chair and Academic Leader Peter Rock, MD, MBA Announces Retirement; Endowed Professorship to be Established in His Name
Peter Rock, MD, the Dr. Martin Helrich Professor and Chair of Anesthesiology at the University of Maryland School of Medicine (UMSOM), announced recently that he will retire at the end of June after a distinguished academic career at the UMSOM, including 17 years as Chair of the Department of Anesthesiology.
Monday, June 09, 2025
On to The Next Chapter: UMSOM Graduates the Class of 2025
The University of Maryland School of Medicine (UMSOM) graduated 138 new physicians into the practice of medicine on May 22 at the historic Hippodrome Theatre. Distinguished members of the Class of 2025 gathered with family, friends, faculty, and staff to celebrate the culmination of years of hard work and perseverance.
Thursday, May 29, 2025
New Pulmonary Arterial Hypertension Treatment Offers Hope for Patients in Advanced Stage of Disease
A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results were published on Wednesday, May 28, in The New England Journal of Medicine and could have “transformative implications” for patients, according to an editorial that accompanied the study written by Bradley Maron, MD, Professor of Medicine and Director of the Hypertension Program at the University of Maryland School of Medicine.
Friday, May 23, 2025
Kahlert Institute for Addiction Medicine Finds Innovative Approaches to Fighting Fourth Wave of Opioid Public Health Crisis
As the U.S. battles a fourth wave of a drug overdose public health crisis that is claiming 300 lives a day, the University of Maryland School of Medicine’s Kahlert Institute for Addiction Medicine marks two years since its founding with a renewed sense of mission and purpose: to find new treatments and approaches to discovery that will save lives and reverse the stigma associated with addiction.
Thursday, May 15, 2025
Using Testosterone Gel to Treat Women Recovering from Hip Fractures Provides No Added Benefits, Clinical Trial Finds
Hip fractures, often a result of a fall, are the most serious type of osteoporotic fracture because they are accompanied by considerable pain, loss of muscle and bone strength, reduced mobility and independence with daily activities, and increased risk for future fractures and death. More than 200,000 American women every year experience hip fractures, and up to three-quarters of them never fully regain their ability to resume normal activities like walking, even after undergoing weeks of exercise rehabilitation. In a pressing effort to test new treatments, researchers conducted a clinical trial to see whether applying a testosterone gel with exercise could improve function and mobility in these patients.
Wednesday, May 14, 2025
Nationally Recognized Emergency Radiologist Tarek Hanna, MD, Named New Chair of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine
UMSOM Dean Mark T. Gladwin, MD, announced today that Tarek N. Hanna, MD, FASER, a nationally recognized expert in emergency and trauma radiology, has been named the new Chair of UMSOM’s Department of Diagnostic Radiology & Nuclear Medicine, President of University of Maryland Diagnostic Imaging Specialists and Chief of Diagnostic Radiology and Nuclear Medicine Clinical Service at University of Maryland Medical Center, following a national search.
Monday, May 12, 2025
UMGCCC Researchers Share New Findings on Link Between Lifetime Alcohol Use and Colorectal Cancer and More at AACR 2025
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) researchers, who are on faculty at the University of Maryland School of Medicine, presented findings at the American Association for Cancer Research (AACR) Annual Meeting in Chicago last month.
Tuesday, May 06, 2025
In First-of-Its-Kind Surgery, Rare Spinal Tumor Removed Through Patient’s Eye Socket at University of Maryland Medical Center
In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully removed a rare cancerous tumor wrapped around the spine and spinal cord of a 19-year-old woman – through her eye socket (orbit).
Tuesday, May 06, 2025
UM Medical Alumni Association Honors Maurice Reid ‘99 and Diana Rickard ‘05
The Medical Alumni Association of the University of Maryland, Inc. (MAA) honored two outstanding physicians, Maurice N. Reid, MD, ’99 and Diana G. Rickard, MD, '05, for their transformative impacts in medicine at the 150th Harry & Vivian Kramer Awards Luncheon & Business Meeting on May 2.
Monday, April 28, 2025
New Innovation Alliance Aims to Drive New Med Tech Ventures In Region
and investors together with physician-scientists, surgeons, and medical technologists promises to launch the Baltimore region as a major national hub for new biomedical ventures and start-up companies. The initiative, called the “Innovation Alliance,” leverages the region's national and international leadership in biomedical research and technology to attract venture capital, foster startups, drive economic growth, and ultimately bring to market new treatments, cures, and technologies that will directly improve lives.
Tuesday, April 22, 2025
While AI Could Be the Game Changer in Predicting Health Outcomes It Should Not Be the Only Method
With the advent of artificial intelligence (AI), predictive medicine is becoming an important part of healthcare, especially in cancer treatment. Predictive medicine uses algorithms and data to help doctors understand how a cancer might continue to grow or react to specific drugs—making it easier to target precision treatment for individual patients.
Thursday, April 17, 2025
Faculty Address Future of Federal Research Funding in National Media Panel
Researchers at the University of Maryland, Baltimore addressed members of the media on Thursday, April 3 to discuss ongoing impacts of cuts to federally funded medical research and the future of academic medicine. From the potential of GLP-1 antagonists, like Ozempic, in addiction medicine to blood tests for early cancer diagnosis, researchers provided reporters an inside look at how lifesaving interventions could be hampered by the loss of federal funding.
Tuesday, April 15, 2025
Largest Genome-Wide Association Study Uncovers New Drug Targets and Potential Therapies for Osteoarthritis
About one in five American adults have osteoarthritis, the most common form of arthritis, according to the Centers for Disease Control and Prevention. No treatment, however, exists to target the disease itself only to help patients manage symptoms like joint pain, stiffness and mobility issues. In an effort to learn more about the genetic underpinnings of the condition –which is expected to afflict 1 billion people worldwide by 2050 – a team of international researchers conducted the largest genome-wide association study ever performed on osteoarthritis.
Wednesday, April 09, 2025
Unite for Hope: Maryland Half Marathon & 5K Calls on Runners and Walkers to Fuel Cancer Research
Marking its 17th year, the Maryland Half Marathon & 5K returns to the Maple Lawn community in Howard County on Saturday, June 7, 2025. This signature event empowers runners, walkers, and fundraisers to join forces against cancer, driving critical support for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). Since 2009, the Maryland Half Marathon & 5K has raised over $6 million, fueling groundbreaking research and compassionate patient care.
Friday, April 04, 2025
Here’s to New Beginnings: UM School of Medicine Celebrates Match Day
Fourth-year medical students had a suspenseful day on Friday, March 21, as they gathered with family, faculty and staff to learn where they are headed off to residency in the annual ritual known as “Match Day”. Consistent with previous years, the 132 graduating seniors at the University of Maryland School of Medicine (UMSOM) had extremely high success with a 98 percent match rate.
Thursday, April 03, 2025
$12.75M MPower Grant to Spur Biomedical Tech Advances at 4MLK
A new five-year, $12.75 million grant from the University of Maryland Strategic Partnership: MPowering the State (MPower) aims to accelerate breakthroughs in biomedical technology and innovations through a collaboration between the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore (UMB).
Thursday, April 03, 2025
Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
Wednesday, April 02, 2025
Researchers Reveal Key Brain Differences to Explain Why Ritalin Helps Improve Focus in Some More Than Others
Nearly 16 million American adults have been diagnosed with attention deficit hyperactivity disorder (ADHD), but evidence suggests that more than 30 percent of them don’t respond well to stimulant medications like Ritalin and Adderall. A new clinical trial provides a surprising explanation for why this may be the case: There are individual differences in how our brains circuits are wired, including the chemical circuits responsible for memory and concentration, according to a new study co-led by the University of Maryland School of Medicine (UMSOM) and performed at the National Institutes of Health (NIH) Clinical Center.
Tuesday, March 25, 2025
Internationally Recognized Vaccine Expert Dr. Paul Offit to Deliver Graduation Address to the University of Maryland School of Medicine’s 216th Graduating Class
Leading vaccine advocate Paul Offit, MD, an internationally recognized immunologist and virologist, will deliver the keynote address for this year’s graduating medical student class. He is best known as co-inventor of the rotavirus vaccine, RotaTeq, which is universally recommended for infants by the CDC and has been credited for saving hundreds of lives every day.
Monday, March 24, 2025
Susan Kinter Named as New President and CEO of the Maryland Medicine Comprehensive Insurance Program
Susan Kinter, BSN, JD, stepped into her new role at MMCIP on February 24 after serving in successive executive roles at the organization since 1998. In her new role, she will guide MMCIP in its core missions to ensure physician, staff, and patient safety across all the University of Maryland system member organizations and practice groups, as well as administering the Health Professional Liability Insurance Program for physicians and nurses.
Thursday, March 13, 2025
UMSOM Rising Third-Year Medical Students Celebrate Transition to Clinical Care Training at Annual Student Clinician Ceremony
The University of Maryland School of Medicine (UMSOM) celebrated 165 rising third-year medical students at the Annual Student Clinician Ceremony on March 4, as they prepare to begin their clinical care training. Over the next two years, students will transition from the classroom to the bedside to gain experience seeing patients through a wide variety of specialties within local healthcare organizations.
Wednesday, March 12, 2025
Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age. This study provided evidence that formed the basis for the World Health Organization’s (WHO) decision last year to recommend the pentavalent Men5CV meningitis vaccine for infants ages 9 months and older.
Tuesday, March 11, 2025
First ever UMSOM "Shark Tank" competition for biomedical research awards $120,000 for innovative faculty projects
The members of the University of Maryland School of Medicine (UMSOM) Board of Visitors (BOV) regularly serve as advisors to the school on strategic planning, fundraising, and philanthropy. But on December 17, the Board members took on a new role for the very first time — they became “sharks.”
Tuesday, March 04, 2025
In Memoriam: Dr. Joseph S. McLaughlin
Dr. Joseph S. McLaughlin had a distinguished and longstanding affiliation with the University of Maryland School of Medicine (UM SOM) and the University of Maryland Medical Center (UMMC) spanning 66 years. His profound impact on medical education, patient care, and surgical innovation leaves a lasting legacy at the University of Maryland.
Wednesday, February 26, 2025
Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.
Friday, February 21, 2025
UM School of Medicine Dermatology Researchers Discover New Skin Disease Using Innovative Diagnostic Platform
A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no effective treatments beyond symptom management. Now a new study could pave the way for precision-medicine based diagnostic testing and targeted treatment.
Wednesday, February 19, 2025
UM Greenebaum Comprehensive Cancer Center Executive Director, Taofeek K. Owonikoko, MD, PhD, named one of the 25 Black Marylanders to Watch by The Baltimore Sun
Taofeek K. Owonikoko, MD, PhD, Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), has been named one of the 25 Black Marylanders to Watch for 2025 by The Baltimore Sun.
Friday, February 07, 2025
UM School of Medicine Surgeon-Scientist to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults
Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic surgeons have repaired a common fracture of the upper part of the thigh bone, or femur, near the hip using screws and plates to piece together slightly separated pieces of bone. But many surgeons now treat these “minimally displaced” femoral neck fractures by replacing the hip joint with a metal implant.
Wednesday, February 05, 2025
Two UM School of Medicine Faculty Appointed as 2025 MPower Professors
The University of Maryland Strategic Partnership: MPowering the State (MPower) today announced the appointment of seven professors from the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) as 2025 MPower Professors.
Wednesday, January 15, 2025
University of Maryland, Baltimore and Wexford Science & Technology Cut Ribbon on 4MLK Building
The University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC, celebrated the grand opening of 4MLK, the newest addition to the University of Maryland BioPark, with a ribbon-cutting ceremony. The event brought together distinguished guests, including Lieutenant Governor Aruna Miller and Mayor Brandon Scott, alongside University and Wexford leaders, neighborhood representatives, innovation community members, economic development officials, and BioPark tenants.
Wednesday, January 15, 2025
Jeremy L. Davis, MD, Named UMGCCC Surgical Oncology Lead and Chief of the Division of Surgical Oncology at UMSOM
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, will serve as the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research.
Tuesday, January 14, 2025
University of Maryland, Baltimore and University of Maryland, College Park Announce $10 Million Joint Gift from Edward and Jennifer St. John and the Edward St. John Foundation for New Center for Translational Engineering and Medicine
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) are pleased to announce a $10 million joint gift from Edward and Jennifer St. John and the Edward St. John Foundation. This landmark investment will launch the Edward & Jennifer St. John Center for Translational Engineering and Medicine (CTEM), a collaboration between the University of Maryland School of Medicine (UMSOM) at UMB and the A. James Clark School of Engineering at UMCP. Together, researchers from these distinct disciplines will tackle a broad spectrum of generational health challenges and drive medical innovations that benefit patients in Maryland and beyond.
Monday, January 13, 2025
UMMS Rolls Out Virtual 'NEST' to Support Bedside Care Teams in Labor and Delivery Units Across the System
The University of Maryland Medical System (UMMS) has launched NEST (Neonatal Outcomes Impacted by Escalation Safety Telemetry), a groundbreaking remote fetal monitoring center that offers continuous, real-time monitoring of critical elements of labor and delivery across System hospitals. NEST is led by a medical director and team of highly specialized nurses who bring more than 200 years of combined experience in safely delivering thousands of babies.
Monday, January 13, 2025
Experts Propose New Framework for Evaluating Sex in Clinical Algorithms to Reduce Bias and Ensure Legality
Many physicians are now using algorithms that consider a patient’s sex, like heart disease risk assessment tools, to help with clinical decision-making. Reliance on these algorithms may result in men and women receiving different care or having different eligibility for healthcare resources, for example placement on an organ transplant list.
Wednesday, January 08, 2025
Presenting a Path Forward for Future Genetically-Modified Pig Heart Transplants: Lessons Learned from Second Patient
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ. Lawrence Faucette, 58, received a pig heart at the University of Maryland Medical Center in 2023 to treat his end-stage heart failure. He lived for 40 days before choosing to forgo additional treatment after the transplant began to fail due to rejection.